Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin to Prevent Lung Damage in Preterm Newborns
NCT03485703Phase 4Completed
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Aug 2012
- Primary completion
- Apr 2016
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of azithromycin in bronchopulmonary dysplasia (BPD), sponsored by Hospital de Clínicas de Porto Alegre. Started Aug 2012; status: completed.
02
Drugs
azithromycin
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT03485703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03485703.